Related content

Matrix metalloproteinase-2 and -9 in the sera and in the urine of human oncocytoma and renal cell carcinoma

By  

Oncology Reports, Vol. 28, Iss. 3, 2012-01 ,pp. : 1051-1056

Spandidos Publications

Access to resources Recommend Favorite

The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma

By Lu Hongsheng   Yang Zhaohui   Zhang Hui   Gan Meifu   Zhou Tao   Wang Siling  

Experimental and Therapeutic Medicine, Vol. 5, Iss. 3, 2013-03 ,pp. : 890-896

Spandidos Publications

Access to resources Recommend Favorite

Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma

By                

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3585-3592

Spandidos Publications

Access to resources Recommend Favorite

Differential Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Protein and mRNA in Epithelial Ovarian Tumors

By Huang L.-W.   Garrett A.P.   Bell D.A.   Welch W.R.   Berkowitz R.S.   Mok S.C.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 369-376

Elsevier

Access to resources Recommend Favorite

Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma

By Tas Faruk   Duranyildiz Derya   Oguz Hilal   Disci Rian   Kurul Sidika   Yasasever Vildan   Topuz Erkan  

Medical Oncology, Vol. 22, Iss. 1, 2005-03 ,pp. : 39-44

Humana Press, Inc

Access to resources Recommend Favorite